rSIFN-co nasal spray
/ Sichuan Huiyang Life Sci
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
February 26, 2025
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
(clinicaltrials.gov)
- P2 | N=188 | Completed | Sponsor: Sichuan Huiyang Life Science and Technology Corporation | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
April 18, 2024
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
(clinicaltrials.gov)
- P2 | N=188 | Active, not recruiting | Sponsor: Sichuan Huiyang Life Science and Technology Corporation | Trial completion date: Jul 2024 ➔ Dec 2024
Trial completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
November 27, 2023
rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19
(clinicaltrials.gov)
- P2 | N=188 | Active, not recruiting | Sponsor: Sichuan Huiyang Life Science and Technology Corporation | Recruiting ➔ Active, not recruiting | Trial completion date: Feb 2023 ➔ Jul 2024
Enrollment closed • Trial completion date • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1